Correlative analysis of histological profile of the adjoining liver parenchyma with liver enzyme levels in hepatocellular carcinoma and their comparison with chronic liver disease in autopsy cases

Indian Journal of Pathology and Microbiology

Volumn 50, Issue 4, 2007, Pages 711-717

  Vaiphei, Kim ^a,b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b NONE   (India)

Author keywords

Biliary epithelial cell injury; Chronic liver disease; Cirrhosis; HBV; HCC; HCV; Inflammation grading; Portal tract lymphoid aggregate

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B CORE ANTIGEN; HEPATITIS C ANTIGEN; LIVER ENZYME;

ADULT; AGED; ARTICLE; AUTOPSY; CHRONIC INFLAMMATION; CHRONIC LIVER DISEASE; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CARCINOMA; LIVER CIRRHOSIS; LIVER PARENCHYMA; MALE; VIRUS CARCINOGENESIS;

ADULT; AGED; AUTOPSY; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPACIVIRUS; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS, CHRONIC; HUMANS; INFLAMMATION; LIVER; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; TRANSAMINASES;

EID: 37349126907     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. Hepatocellular carcinoma. Ann Intern Med1988; 108:390-401.
2. Nanashima A, Tanaka K, Yamaguchi H, et al. Fibrosis and inflammatory activity in noncancerous tissue and mitotic index of cancer tissue in patients with hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection. Dig Dis Sci2003; 48:1517-22.
3. Miyake S. The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum. Acta Med Okayama 1979; 33:287-304.
4. Shimokawa Y, Okuda K, Kubo Y, et al. Serum glutamic oxalacetic transaminase /glutamic pyruvic transaminase ratios in hepatocellular carcinoma. Cancer1977; 40:319-24.
5. Ng IO, Poon RT, Shek TW, Fan ST. Clinicopathologic and prognostic significance of the histologic activity of noncancerous liver tissue in hepatitis B virus-associated hepatocellular carcinoma. Am J Clin Pathol2002; 117:411-8.
6. Luo JC, Hwang SJ, Lai CR, et al. Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan. J Gastroenterol Hepatol1998; 13:685-90.
7. Brechot C, Jaffredo D, Lagorce D, Gerken G, Meyer zum Buschenfelde K. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinoma in Europe: result of a European concerted action. J Hepatol1998; 29:73-83.
8. Edamota Y, Tani M, Kurata T, Abe K. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissue. Cancer 1996; 77:1787-91.
9. Kubicka S, Rudolph KL, Hanke M, et al. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.Liver2000; 20:312-8.
10. nd edn. New York,: Oxford University press, 1996: 141-67.
11. Sarin SK, Thakur V, Guptan RC, et al. Profile of hepatocellular carcinoma in India: An insight into the possible etiologic association. J Gastroenterol Hepatol2001; 16:666-73.
12. Ersoy Y, Bayraktar NM, Mizrak B, et al. The level of endothelin-1 and nitric oxide in patients with chronic viral hepatitis B and C and correlation with histopathological grading and staging. Hepatol Res2006; 34:111-6.
13. Simonetti RG, Camma C, Fiorello F, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case control study. Ann Intern Med1992; 116; 97-102.
14. Kamegaya Y, Haisa Y, Zukerberg L, et al. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatol2005; 41:660-5.
15. Kato N, Yoshida H, Kioko Ono-Nita S, et al. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal transducer. Hepatol2000; 32: 405-12.
16. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol1991; 13:372-4.
17. Garson JA, Ring C, Tuke P, Tedder RS. Enhanced detection by PCR of hepatitis C virus RNA. Lancet1990; 336: 878-9.
18. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000; 160:3227-30.
19. Brechot C, Hadchouel M, Scotto J, et al. State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and negative liver disease. Proc Natl Acad Sci USA1981; 78:3906-10.
20. Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol1996; 70:4438-43.
21. Rozario R, Ramakrishna B. Histopathological study of chronic hepatis B and C: a comparison of two scoring systems. J Hepatol 2003; 38:223-9.
22. Shiratori Y, Shiina S, Imamura M, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatol1995; 22:1027-33.
23. Vaiphei K, Pal N S, Arora S K. Compararive analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease- ana autopsy based study. Ind J Pathol Microbiol 2006; 49:357-61.
24. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol1994; 17: 71-91.
25. Joshi N, Kumar A, Rani MS, Chandra N, Ramanjaneyulu ER.Clinical and eatiological profile of hepatoma at a tertiary care centre. Trop Gastroenterol2003; 24:73-5.
26. Shiratori Y, Shiina S, Zhang PY, et al. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer1997; 80:2060-7.